Form 4 for RPRX Royalty Pharma plc
Accepted 2025-01-02 00:00:00 ET · period of report 2024-12-31 · accession 0001802768-25-000005 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-01-02 | 2024-12-31 | RPRX | Fernandez Henry A | Dir | A - Grant | $24.94 | +1,503 | 55.5K | +3% | +$37.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Ordinary Shares | 2024-12-31 | A | A | 1,503 | $24.94 | 55,505 | D | — | — | (F1) Reflects Class A Ordinary Shares issued to the reporting person under the Issuer's 2020 Independent Director Equity Incentive Plan in lieu of a quarterly retainer payment of $37,500. |